semaglutide weight loss surprise Interesting article comparing use in postmenopausal women on, HRT vs. not on HRT, Results not surprising:, · Women on HRT and semaglutide had 30 % more than those not on HRT, · Semaglutide: Weight loss game changer?

There's also an active federal rulemaking worth understanding if you're weighing a compounded GLP-1 program in mid-2026: April 30, 2026 - FDA proposed excluding semaglutide, tirzepatide, and liraglutide from the list of bulk drug substances that large-scale 503B outsourcing facilities may use to compound medications outside a declared drug shortage May 1, 2026 - proposal published in the Federal Register (91 Fed

For detailed appeal strategies, see our complete Wegovy appeals guide

The appetite-suppressing effects become more predictable and reliable as the medication settles into a steady rhythm

Patients who take this route should consult with their doctors about post-GLP-1 weight management strategies

Small, consistent actions lead to measurable results over time, giving you control and confidence in your recovery journey